Effectiveness and Safety of Adalimumab in Patients With Very Early-Onset Inflammatory Bowel Disease: A Retrospective Study on Behalf of the Porto Inflammatory Bowel Disease Working Group of European Society for Pediatric Gastroenterology Hepatology and Nutrition Get access

• Abstract
• Lay summary
• Supplementary data

Breaking Down Barriers: Epithelial Contributors to Monogenic IBD Pathogenesis Free

• Abstract
• Lay summary

Response to Letter to the Editor: “Failure Rate of Antitumor Necrosis Factor Alpha Biologics in Very Early Onset Inflammatory Bowel Disease” Free

• Extract

Efficacy and Safety of Anti-Tumor Necrosis Factor Alpha in Very Early Onset Inflammatory Bowel Disease Free

• Abstract
• Lay summary

Rapid Clinical Remission With Upadacitinib in a Pediatric Patient With Refractory Crohn’s Disease Free